• Explore /
  • Poster
  • / Safety and efficacy of immune checkpoint inhibitors (ICI) in advanced penile squamous cell carcinoma (PeCa): An international study from the Global Society of Rare Genitourinary Tumors (GSRGT).

Safety and efficacy of immune checkpoint inhibitors (ICI) in advanced penile squamous cell carcinoma (PeCa): An international study from the Global Society of Rare Genitourinary Tumors (GSRGT).

Abstract Poster

Authors

null

Talal El Zarif

Dana-Farber Cancer Institute, Boston, MA

Talal El Zarif , Amin Nassar , Lijuan Jiang , Gregory Russell Pond , Tony Zhuang , Maud Velev , Andrew Warren Hahn , Sebastiano Buti , Pablo Álvarez , Rana R. McKay , Bruno Vincenzi , Edward El-Am , Gavin Hui , Jae-Lyun Lee , Tarek H. Mouhieddine , Matthew I. Milowsky , Harrison Matthews , Pedro C. Barata , Andrea B. Apolo , Guru P. Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 5)

DOI

10.1200/JCO.2023.41.6_suppl.5

Abstract #

5

Poster Bd #

D5

Abstract Disclosures

Similar Posters

First Author: Lorenzo Pilla

First Author: Daniel Olson

First Author: Thierry Landre

First Author: Charlee Nardin